Phenoxybenzamine Hydrochloride Capsule — FDA Drug Shortage
The FDA lists a drug shortage record for Phenoxybenzamine Hydrochloride Capsule (capsule) from Advanz Pharma (US) Corp. with status To Be Discontinued. The shortage was first posted on 12/01/2025.
Shortage Details
- Status
- To Be Discontinued
- Company
- Advanz Pharma (US) Corp.
- Package NDC
- 59212-001-02
- Dosage Form
- Capsule
- Presentation
- Dibenzyline, Capsule, 10 mg (NDC 59212-001-02)
- Initial Posting
- 12/01/2025
- Revised Date